Home > Insider Trading > Bioplus Acquisition Corp.

Bioplus Acquisition Corp. (BIOS)

Market is closed

Get Email Alerts

Profile
Hedge Fund Holdings
Insider Purchases
Insider Sales
Institutional Holdings
13 D/G Filings
News

Get Email Alerts

News

First
<< Previous
11 - 20
Next >>

13D Filing: Coliseum Capital and Bioscrip Inc. (BIOS)

this cover page shall not be deemed to be filed for the purpose of Section 18 of the Securities Exchange Act of 1934 (Act) or otherwise subject to the liabilities of that section of the Act but shall...

Keep Reading →

September 11th, 2017 - Hedge Funds

15 Penny Stocks Poised To Explode According To Hedge Funds

Penny stocks are usually defined as shares of small companies that trade under $1 per share, although the SEC defines a penny stock as a security that trades under $5 per share. There are thousands or...

Keep Reading →

September 1st, 2017 - Lists News

13D Filing: Coliseum Capital and Bioscrip Inc. (BIOS)

Keep Reading →

August 21st, 2017 - Hedge Funds

13D Filing: GAMCO Investors and Bioscrip Inc. (BIOS)

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240....

Keep Reading →

August 14th, 2017 - Hedge Funds

13D Filing: GAMCO Investors and Bioscrip Inc. (BIOS)

Keep Reading →

July 14th, 2017 - Hedge Funds

Hedge Funds Are Selling BioScrip Inc. (BIOS)

Billionaire hedge fund managers such as Steve Cohen and Stan Druckenmiller can generate millions or even billions of dollars every year by pinning down high-potential small-cap stocks and pouring cash...

Keep Reading →

December 14th, 2016 - Hedge Funds News

Technically Speaking: BioScrip Inc (BIOS), Hertz Global Holdings, Inc (HTZ) And CVS Health Corp (CVS)

In my "Technically Speaking" analyses, I'll take a look at up to three stocks that have entered into either an overbought or oversold condition.

Keep Reading →

November 9th, 2016 - News Stock Analysis

Bioscrip Inc. (BIOS): Billionaire Mario Gabelli's GAMCO Investors Slightly Lowers Its Stake

Billionaire Mario Gabelli's GAMCO Investors recently filed an amended Form 13D with the US Securities and Exchange Commission, in which it reported slightly lowering its stake in Bioscrip Inc.

Keep Reading →

October 19th, 2016 - Hedge Funds News

Five Cheap Healthcare Stocks Poised to Explode

The healthcare sector has witnessed a significant correction in the last 15 months, with many prominent names in the industry losing a noteworthy chunk of their market capitalization in that time.

Keep Reading →

October 8th, 2016 - Hedge Funds News